Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia

Benjamin M Heyman, MD, Alicia D. Volkheimer, MS, J. Brice Weinberg, MD, Mark Lanasa, MD PhD

Blood (2014) 124 (21): 5631.

https://doi.org/10.1182/blood.V124.21.5631.5631

Published: 2014

Journal Articles

Absolute Monocyte Count and Serum CD14 As Prognostic Markers In Chronic Lymphocytic Leukemia

Daphne R. Friedman, MD, Kathleen K. Harnden, MD,, Youwei Chen, MD, Alicia D. Volkheimer, MS, J. Brice Weinberg, MD

Blood (2013) 122 (21): 5297.

https://doi.org/10.1182/blood.V122.21.5297.5297

Published: 2013

Journal Articles

The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients

Tingyu Liu, BS, J. Brice Weinberg, MD, Evan D. Davis, Alicia D. Volkheimer, MS, Jeffrey Rathmell, PhD

Blood (2012) 120 (21): 1785.

https://doi.org/10.1182/blood.V120.21.1785.1785

Published: 2012

Journal Articles

CD38 Variation in Chronic Lymphocytic Leukemia

Ryan D. Nipp, M.D., J. Brice Weinberg, MD, Alicia D. Volkheimer, M.S., Evan D. Davis, Youwei Chen, MD, Daphne R. Friedman, M.D.

Blood (2012) 120 (21): 4576.

https://doi.org/10.1182/blood.V120.21.4576.4576

Published: 2012

Journal Articles

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

J. Brice Weinberg, MD, David J. DiLillo, PhD, Yohei Iwata, PhD, Takashi Matushita, PhD, Karen M. Matta, BS, Guglielmo M. Venturi, PhD, Giandomenico Russo, MD, PhD, Youwei Chen, MD, Jon P. Gockerman, MD, Joseph O. Moore, MD, Louis F. Diehl, MD, Alicia D. Volkheimer, MS, Daphne R. Friedman, M.D., Mark C Lanasa, MD, PhD, Russell P. Hall, MD, Thomas J. Tedder, PhD

Blood (2011) 118 (21): 286.

https://doi.org/10.1182/blood.V118.21.286.286

Published: 2011

Journal Articles

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target

Dale J. Christensen, Youwei Chen, Jessica Oddo, Karen M. Matta, Jessica Neil, Evan D. Davis, Alicia D. Volkheimer, Mark C. Lanasa, Daphne R. Friedman, Barbara K. Goodman, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Michael P. Vitek, J. Brice Weinberg

Blood (2011) 118 (15): 4150–4158.

https://doi.org/10.1182/blood-2011-04-351072

Published: 2011

Includes: Supplemental data

Journal Articles

The SET Oncogene, a Potent PP2A Inhibitor, Is Elevated in CLL and Antagonism of SET Induces Apoptosis.

Dale J. Christensen, PhD, Karen M. Bond, BS, Alicia D. Volkheimer, MS, Jessica Oddo, BS, Youwei Chen, MD, Jon P. Gockerman, MD, Joseph O. Moore, MD, Louis F. Diehl, MD, Carlos M. de Castro, MD, Michael P. Vitek, PhD, J. Brice Weinberg, MD

Blood (2009) 114 (22): 802.

https://doi.org/10.1182/blood.V114.22.802.802

Published: 2009

Journal Articles

Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity

Blood (2008) 112 (11): 359.

https://doi.org/10.1182/blood.V112.11.359.359

Published: 2008

Journal Articles

Identification of Therapeutic Targets for Chronic Lymphocytic Leukemia in the Relapsed and Refractory Setting.

Daphne Friedman, MD, J. Brice Weinberg, MD, Karen M Bond, Alicia D Volkheimer, Youwei Chen, Joseph R Nevins, PhD

Blood (2008) 112 (11): 2068.

https://doi.org/10.1182/blood.V112.11.2068.2068

Published: 2008

Journal Articles

A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.

Daphne R. Friedman, MD, J. Brice Weinberg, MD, Anil Potti, MD, Alicia D. Volkheimer, Karen M. Bond, Youwei Chen, Ning Jiang, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Carlos M. Decastro, MD, Joseph R. Nevins, PhD

Blood (2007) 110 (11): 3096.

https://doi.org/10.1182/blood.V110.11.3096.3096

Published: 2007

Journal Articles

Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.

J. Brice Weinberg, MD, Ning Jiang, MD, Alicia D. Volkheimer, MS, Youwei Chen, MD, Karen M. Bond, BS, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Carlos M. de Castro, MD, David A. Rizzieri, MD, PhD, Marc C. Levesque, MD, PhD, Kenneth Mugridge, PhD, Joe DeAngelo

Blood (2007) 110 (11): 3129.

https://doi.org/10.1182/blood.V110.11.3129.3129

Published: 2007

Journal Articles

Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia.

J. Brice Weinberg, MD, Alicia D. Volkheimer, MS, Mirta Mihovilovic, PhD, Ning Jiang, MD, Youwei Chen, MD, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Carlos M. de Castro, MD, David A. Rizzieri, MD, Marc C. Levesque, MD, PhD, Robert DeKroon, PhD, Warren J. Strittmatter, MD

Blood (2007) 110 (11): 3081.

https://doi.org/10.1182/blood.V110.11.3081.3081

Published: 2007

Journal Articles

Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification

Alicia D. Volkheimer, J. Brice Weinberg, Bethany E. Beasley, John F. Whitesides, Jon P. Gockerman, Joseph O. Moore, Garnett Kelsoe, Barbara K. Goodman, Marc C. Levesque

Blood (2006) 109 (4): 1559–1567.

https://doi.org/10.1182/blood-2006-05-020644

Published: 2006

Includes: Supplemental data

Journal Articles

Induction of Chronic Lymphocytic Leukemia (CLL) Apoptosis by Nitric Oxide Synthase (NOS) Inhibitors: Drug Efficacy Correlates with Lipid Solubility and NOS1 Dissociation Constant.

Marc C. Levesque, MD, PhD, Dipak K. Ghosh, PhD, Bethany E. Beasley, Youwei Chen, Alicia D. Volkheimer, Charles W. O’Loughlin, Jon P. Gockerman, MD, Joseph O. Moore, MD, J. Brice Weinberg, MD

Blood (2005) 106 (11): 5044.

https://doi.org/10.1182/blood.V106.11.5044.5044

Published: 2005

Journal Articles

Predictors of Survival in CLL: Multivariate Analyses Reveal Significant Correlation with IgV H Gene Mutation Status, Clinical Stage, and Cellular CD38 (but Not Zap-70) Expression.

Alicia D. Volkheimer, MS, Marc C. Levesque, MD, PhD, Bethany E. Beasley, BS, Louis Diehl, MD, Youwei Chen, MD, Gina Vaccaro, MD, Carlos DeCastro, MD, David Rizzieri, MD, Jon P. Gockerman, MD, Joseph O. Moore, MD, J. Brice Weinberg, MD

Blood (2005) 106 (11): 5010.

https://doi.org/10.1182/blood.V106.11.5010.5010

Published: 2005

Journal Articles

A Single Cell Analysis of Immunoglobulin Genes in Chronic Lymphocytic Leukemia (CLL): Evidence of Intraclonal Diversification Associated with Progressive Somatic Mutations and Progressive Antigen Drive in Immunoglobulin Heavy and Light Chains.

Marc C. Levesque, MD, PhD, Alicia D. Volkheimer, Bethany E. Beasley, Jon P. Gockerman, MD, Joseph O. Moore, MD, J. Brice Weinberg, MD

Blood (2005) 106 (11): 1186.

https://doi.org/10.1182/blood.V106.11.1186.1186

Published: 2005

NARROW

Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia

Absolute Monocyte Count and Serum CD14 As Prognostic Markers In Chronic Lymphocytic Leukemia

The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients

CD38 Variation in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target

The SET Oncogene, a Potent PP2A Inhibitor, Is Elevated in CLL and Antagonism of SET Induces Apoptosis.

Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity

Identification of Therapeutic Targets for Chronic Lymphocytic Leukemia in the Relapsed and Refractory Setting.

A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.

Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.

Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia.

Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification

Induction of Chronic Lymphocytic Leukemia (CLL) Apoptosis by Nitric Oxide Synthase (NOS) Inhibitors: Drug Efficacy Correlates with Lipid Solubility and NOS1 Dissociation Constant.

Predictors of Survival in CLL: Multivariate Analyses Reveal Significant Correlation with IgV H Gene Mutation Status, Clinical Stage, and Cellular CD38 (but Not Zap-70) Expression.

A Single Cell Analysis of Immunoglobulin Genes in Chronic Lymphocytic Leukemia (CLL): Evidence of Intraclonal Diversification Associated with Progressive Somatic Mutations and Progressive Antigen Drive in Immunoglobulin Heavy and Light Chains.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only